Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/NMPA/Potassium Sodium Hydrogen Citrate Granules

Approved

化学药品

Potassium Sodium Hydrogen Citrate Granules

Viatris Healthcare GmbH🇨🇳 National Medical Products Administration

Approval Date: Feb 28, 2022
Approval ID: 8EuHRcUIBSP
Company: Viatris Healthcare GmbH
Type: 化学药品

Approval Details

Approval Id: 8EuHRcUIBSP
Approval Number: 国药准字HJ20181128
Generic Name: 枸橼酸氢钾钠颗粒
Generic Name En: Potassium Sodium Hydrogen Citrate Granules
Trade Name: 友来特
Drug Type: 化学药品
Dosage Form: 颗粒剂
Strength: 97.1g/100g
Reg Date: 2022-02-28
Expired Date: 2027-02-27
Company Name: Viatris Healthcare GmbH
Company Detail Path: /organization/viatris-healthcare-gmbh

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Feb 28, 2022

Approval ID

8EuHRcUIBSP

Type

化学药品

Back to NMPA Approvals

友来特 - NMPA Drug Approval Details